Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First tranche of €20m European Investment Bank loan drawn today

February 5th, 2018, Örnsköldsvik, Sweden - Clavister, a leader in high-performance network security solutions, drew its first tranche of funding from the European Investment Bank (“EIB”) today under the finance contract dated December 18, 2017 (see related press release of the Summon to the EGM and the Press Conference and EIB signing ceremony). The total sum drawn today is €10m, out of the total €20m loan made available to Clavister AB; the remaining two tranches amounts to up to €5m each. The use of proceeds of the loan is to support Clavister’s growth ambitions, investing in further

#18-204 Listing of Knock out warrants issued by Commerzbank AG

As from February 06, 2018, 5 Knock out warrants issued by Commerzbank AG will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from February 06, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

Oncology Venture is represented at the 4th Biotech & Money World Congress in London, 5-6th February.

Hørsholm, Denmark, 5th of February 2018 – Oncology Venture Sweden AB (OV:ST) reports from the 4th Biotech & Money World Congres. Oncology Venture have scheduled meetings with several companies on the 5-6th February. These companies are potential investors or biotech/pharma with interest in either in-licensing or co-development of oncology drugs or companies with drugs of interest to Oncology Venture for in-licensing. Further, OV will give a presentation of the company on the 6th February. For further information, please contact: Ulla Hald Buhl, COO och chef för IR & kommunikation

#18-203 Listing of Knock out warrants issued by Commerzbank AG

As from February 06, 2018, 5 Knock out warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from February 06, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

Appointments Committee's proposal regarding composition of Raute Corporation's Board of Directors

RAUTE CORPORATION STOCK EXCHANGE RELEASE 5 FEBRUARY 2018 at 2:45 p.m.APPOINTMENTS COMMITTEE'S PROPOSAL REGARDING COMPOSITION OF RAUTE CORPORATION'S BOARD OF DIRECTORS Raute Corporation's Appointments Committee has informed that it will propose to the Annual General Meeting convening on 22 March 2018 that the number of the Board members is six. The Appointments Committee proposes that Mr. Erkki Pehu-Lehtonen, M.Sc. (Eng.), be re-elected as Chairman of the Board of Directors, Mr. Mika Mustakallio, M.Sc. (Econ.), be re-elected as Vice Chairman of the Board of Directors and Mr. Joni Bask,

Reminder - SpareBank 1 SR-Bank ASA: Presentation of preliminary annual accounts 2017

SpareBank 1 SR-Bank’s preliminary accounts 2017 and 4th quarter will be released at 07.15 am on Wednesday 7 February 2018, and we would like to invite you to a presentation. Time :                   Wednesday 7 February 2018, 08.00 am Location:             SpareBank 1 Markets, Olav V's gate 5 Breakfast is served from 07.40 am For those who are unable to attend the presentation there will be a live web-TV broadcast (in norwegian) www.sr-bank.no The presentation will be made by CEO Arne Austreid and CFO Inge Reinertsen SpareBank 1 SMN will make their presentation of

Oncology Venture appoints new Chief Financial Officer

Hoersholm, Denmark, February 5thh, 2018 – Oncology Venture Sweden AB (AktieTorget: OV) announces that the company reinforces its organization by the recruitment of Claus Frisenberg Pedersen to the position as Chief Financial Officer (“CFO”) and Chief Commercial Officer (“CCO”). Claus Frisenberg Pedersen will replace CFO Nikolaj Buhl Jensen, who will take a position as Senior Consultant in the management company Buhl Oncology (Buhl Krone Holding APS) – a major investor in Oncology Venture Sweden AB and Medical Prognosis Institute A/S.Claus Frisenberg Pedersen (b. 1972) has a strong

Skanska to build the Urban Environment House in Helsinki, Finland, for EUR 83M, about SEK 800M

Skanska has signed a contract with the City of Helsinki to build the Urban Environment House in Helsinki, Finland. The contract is worth EUR 83M, about SEK 800M, which will be included in the Nordic order bookings for the first quarter 2018.The seven storey building in the Kalasatama area of Helsinki will comprise of about 40,000 gross square meters of office space. In addition, there will be one underground level, with parking spaces for cars and bikes. At the upper levels, there will be several terraced spaces that can be used for work, recreation or meetings. The facades of the Urban

UPM studies opportunities for developing its biofuels business by starting an environmental impact assessment in Kotka, Finland

(UPM, Helsinki, 5 February 2018 at 14:00 EET) - UPM is studying biofuels development opportunities by starting an environmental impact assessment (EIA) for a possible biorefinery in Mussalo, Kotka, in south-eastern Finland. The study of a possible Kotka Biorefinery is in the very early stages and the EIA process normally takes approximately one year. EU and national policies on biofuels will also play an important role in the final assessment of the possible investment. The EIA study states that the proposed second UPM biorefinery would use a different raw material base and technology

End-year report 2017

Increased rental income and record high net letting · Rental income increased to SEK 2,280m (2,105). In an identical portfolio, income rose by approximately 9,5 per cent. · Net operating income increased with 11.5 per cent to SEK 1,680m (1,507) · The surplus ratio was 74 per cent (72). · Profit from property management rose to SEK 992m (471). · Realised and unrealised changes in value amounted to SEK 6,095m (8,105) · Net lettings during the year totalled SEK 244m (127). · After-tax profit for the year amounted to SEK 5,632m (7,107), corresponding to SEK 34.05 per

CLS participates in the ”10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer” in the Netherlands

Clinical Laserthermia Systems AB (publ) participates in the ”10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer” in Noordwijk, in the Netherlands, on 11-13 February. The conference is about using focal therapy and advanced diagnostic imaging, when treating cancer in prostate and kidney, and is primarily addressing urologists.  CLS will present a poster titled ”Characterization of TRANBERG | Laser Applicator of diffuser type for Focal Laser Ablation in prostate cancer”,  describing the results from ex-vivo tests with focal laser ablation (FLA) using

ROM-7510 Qseven Module with Integrated Cortex®-A15 and DSP Processors

for Accelerated Multimedia and Industrial Communication in Advanced IoT ApplicationFeb. 5th, 2018, Taipei—Advantech, a leader of the global industrial computing market, is pleased to announce the release of the latest ROM-7510 Qseven module. The ROM-7510 is powered by TI’s AM5728, consisting of dual Arm® Cortex®-A15 microprocessors and dual TI C66x™ DSP processors, enabling high computing processing capability, accelerated multimedia, and industrial communication. The newly launched ROM-7510 computer-on-module complies with standard Qseven 2.0 and 2.1 form factors, and its many interfaces

Stena Line’s new RoPax vessels beginning to take shape

On Friday 2 February 2018, the official keel-laying ceremony took place at the AVIC Weihai Shipyard in China.   This traditional maritime event marks the start of the construction phase of the hull and the exterior parts of the vessel. Niclas Mårtensson, CEO Stena Line, together with Magnus Olsson, Project Manager Stena RoRo, about to place the coin under the keel. “This is an important milestone in our exciting new ship building project”, said Niclas Mårtensson, CEO Stena Line, who also took part in the traditional Coin Ceremony where 4 coins (GBP, EUR, SEK and RMB) where

Millicom appoints Stephen McFarland as Special Representative in Guatemala

Luxembourg, February 5th, 2018 – Millicom announced today it has appointed Ambassador (retired) Stephen McFarland as Special Representative of Millicom in Guatemala. McFarland joins Millicom with 37 years of experience as a U.S. Foreign Service Officer across Latin America, as well as assignments to Iraq and Afghanistan. He first served in Guatemala as Deputy Chief of Mission and later as Chargé d’Affaires from 2000 to 2003, before returning to serve as the U.S. Ambassador to Guatemala between 2008 and 2011.  McFarland holds a B.A. in Economics from Yale University.    McFarland’s

Payment of consent fee in Cherry’s bond loan

Cherry AB (publ)’s – STO: CHER-B.ST – up to EUR 200,000,000 Senior Secured Bonds 2016/2020 with ISIN SE0008321616.On 22 December 2017, a notice of written procedure was sent to the Bondholders, regarding a request of certain amendments of the Terms and Conditions. The written procedure was approved 22 January 2018. Following the approval of the written procedure a consent fee shall be paid to the Bondholders whom where registered as bondholders in the Issuer’s debt register kept by Euroclear Sweden on the Consent Fee Record Date, originally planned to be 29 January 2018. The Consent Fee

There are no items matching the current filter
There are no more items matching the current filter
Back to top